Home
Conditions
Carcinoma, Non-Small-Cell Lung

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,696 public trials 1,038 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Not Yet Recruiting

Tumor Associated Neutrophils as a Biomarker of Chemo-immunotherapy Response in Locally Advanced Non-small Cell Lung Cancer : a Model Based on Neoadjuvant Strategy

NCT06974097

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: CHU de Montpellier - Hôpital Arnaud de Villeneuve Montpellier, Cedex 5, France

View Trial Details

Not Yet Recruiting

PANK-003 Cell Injection Combined With Standard Adjuvant Chemotherapy After Surgery in Patients With Stage IIIA NSCLC

NCT07043907

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Prospective, Single-arm, Phase II Clinical Study of Tislelizumab Combined With Anlotinib and Platinum-based Doublet Perioperative Therapy for Resectable Stage II-IIIB Driver Gene-negative NSCLC

NCT06977828

Conditions: Adjuvant Immunotherapy, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations: The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Not Yet Recruiting

Risk and Prognosis of Brain Metastasis in Non-Small Cell Lung Cancer

NCT07034365

Conditions: Brain Diseases, Brain Metastases From Non-small Cell Lung Cancer (NSCLC), Brain Neoplasms, +15 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Clinical Outcomes of Tislelizumab Combined With Chemotherapy as Induction Therapy in Stage III (cTNM-IIIB/IIIC) NSCLC

NCT06829641

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors

NCT07036185

Conditions: Bile Duct Cancer, Bile Duct Diseases, Bile Duct Neoplasms, +36 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer

NCT07035860

Conditions: Bronchial Neoplasms, Carbon Ion Radiotheray, Carcinoma, Bronchogenic, +8 more
Locations: Zhejiang Cancer Hospital Hangzhou, Zhejiang, China

View Trial Details

Not Yet Recruiting

Enteral Nutrition With L-Carnitine for Cachexia in Non-Small Cell Lung Cancer

NCT07035444

Conditions: Body Weight, Body Weight Changes, Bronchial Neoplasms, +15 more
Locations: Daping Hospital and the Research Institute of Surgery of The Third Military Medical University Chongqing, China

View Trial Details

Not Yet Recruiting

A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer

NCT07031154

Conditions: Adebrelimab, Apatinib, Bronchial Neoplasms, +10 more
Locations: First Affiliated Hospital of Xiamen University Xiamen, Fujian, China

View Trial Details

Not Yet Recruiting

PD-1 Combined With Bevacizumab and PCSK-9 Inhibitor in Patients With Advanced NSCLC Who Have Progressed After Anti- PD- 1/L1 Therapy

NCT07014215

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Not specified

View Trial Details

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung trial results

Related conditions